Pediatr. praxi. 2012;13(4):247-249

The new possibilities for extemporaneous cutaneous preparations in pediatrics

PharmDr.Zbyněk Sklenář, Ph.D., MBA1,2, Mgr.Kateřina Horáčková2, doc.MUDr.Ondřej Slanař, Ph.D.1
1 Farmakologický ústav, 1. lékařská fakulta, Univerzita Karlova v Praze
2 Lékárna Na Rohožníku, Praha

In recent years magistral preparation has been enriched with several new substances. This paper presents some possibilities of extemporaneous

preparation – semisolid preparations intended for the skin or mucosa application with local effect, suitable for pediatric

use. It introduces in detail three substances – dexpanthenol, sodium lactate solution and almond oil. The article presents examples of

suitable recipes for pediatric use: water-in-oil (w/o) cream with dexpanthenol and urea for infants, epithelizing ointment with vitamine E,

oil-in-water (o/w) cream with glycerine, nasal emulsion gel with vitamine E (Nasopanthil), ointment containing purified almond oil, zinc

oxide, dimeticone and vitamine E, cooling emolient cream and as suitable topical antimycotic an oil gel with nystatine is introduced.

Keywords: formulation in pharmacies, magistral (compounded) preparation, dexpanthenol, almond oil, sodium lactate solution

Published: August 24, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Sklenář Z, Horáčková K, Slanař O. The new possibilities for extemporaneous cutaneous preparations in pediatrics. Pediatr. praxi. 2012;13(4):247-249.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Wollina U, Nissen HP, Kubicki J. Antientzündliche Wirkungen von Dexpanthenol. Akt Dermatol 2004; 30(11): 478-482. Go to original source...
    2. Höger PH. Kinderdermatologie: Differenzialdiagnostik und Therapie bei Kindern und Jugendlichen. 2. vyd. Schattauer GmbH: Stuttgart. 2007: 569.
    3. Peuke C, Dreeke-Ehrlich M. Rezeptur Leitlinien für die rationale Herstellung. Stuttgart: Deutscher Apotheker Verlag Stuttgart, 2005: 337.
    4. Gloor M, Senger B, Gehring W. Wirkt eine Kombination von Dexpanthenol und Glycerin stärker hydratisierend als die Einzelkomponenten allein? Akt Dermatol 2002; 28(11): 402-405. Go to original source...
    5. Sklenář Z. Nová emoliencia s obsahem močoviny v magistraliter přípravcích. Čes.-slov. Derm. 2010; 85(5): 274-279. Go to original source...
    6. Hašek J. Dexpanthenol v léčbě kožních onemocnění. Dermatol. praxi 2011; 5(1): 41-44.
    7. Sklenář Z. Riziková léčiva v pediatrické dermatologické magistraliter receptuře a jejich vhodné alternativy. Pediatr. praxi 2010; 11(4): 232-235.
    8. Sklenář Z. Galenická úskalí při zapracování močoviny do lokálních polotuhých základů používaných v magistraliter receptuře. Čes.-slov. Derm. 2007; 82(6): 334-339. Go to original source...
    9. Gloor M, Thoma K, Fluhr J. Dermatologische Externatherapie. Berlin, Heidelberg: Springer-Verlag, 2000: 469. Go to original source...
    10. Český lékopis 2009, dopl. 2010. [CD-ROM]. Praha: Grada Publishing, a.s., 2010.
    11. Deplazes C, Möll F, Gloor St, Panizzon R. Dermatologische Magistralrezepturen der Schweiz. 3. rozšíř. vyd. Winterthur: 2010: 264.
    12. Kinget R. Galenisch formularium Met inleiding op het medisch voorschrift. 2. revid. vyd. Leuven/Apeldoorn: Garant 2000: 235.
    13. Hašek J. Mandlový olej v magistraliter receptuře. Prakt. lékáren. 2011; 7(4): 176-179.
    14. Sklenář Z, Horáčková K. Nové léčivé látky v magistraliter receptuře VII - Tokoferol-alfa-acetát. Prakt. Lékáren. 2011; 7(1): 30-33.
    15. Státní ústav pro kontrolu léčiv, databáze léků. Dostupné z: http://www.sukl.cz/modules/medication/search.php [cit. 2012-03-12].
    16. Wolf G, Süverkrüp R. Rezepturen Probleme Erkennen, Lösen, Vermeiden. Stuttgart: Deutscher Apotheker Verlag Stuttgart, 2002: 155.
    17. Wolf G, Höger PH. Hypoallergenic and non-toxic emollient therapies for children. J Dtsch Dermatol Ges 2009; 7(1): 50-60. Go to original source... Go to PubMed...
    18. Čapková Š, Kohoutová V. Nebezpečí zevní léčby kožních onemocnění v dětském věku. Čs pediat. 1994; 49 (1): 38-43.

    Return to the content


    Internal Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.